243 related articles for article (PubMed ID: 33163397)
1. Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Yang J; Bao Y; Chen W; Duan Y; Sun D
Front Oncol; 2020; 10():551668. PubMed ID: 33163397
[TBL] [Abstract][Full Text] [Related]
2. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
3. Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Ma E; Li J; Xing H; Li R; Shen C; Zhang Q; Ma Z; Tao Y; Qin L; Zhao J; Wang Z
Ann Transl Med; 2021 Mar; 9(6):468. PubMed ID: 33850865
[TBL] [Abstract][Full Text] [Related]
4. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
6. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
Front Oncol; 2021; 11():742630. PubMed ID: 34745962
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
[TBL] [Abstract][Full Text] [Related]
8. Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular Carcinoma.
Lin K; Huang Q; Wang L; Zeng J; Ding Z; Liu H; Fu J; Guo P; Chen Z; Zeng Y; Zhou W; Liu J
Front Oncol; 2021; 11():612588. PubMed ID: 33680963
[TBL] [Abstract][Full Text] [Related]
9. Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy.
Ma C; Cao Y; Zhang G; Qiu J; Zhou Y; Wang P; Wang S; Yan D; Ma D; Jiang C; Wang Z
J Hepatocell Carcinoma; 2023; 10():217-230. PubMed ID: 36798739
[TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.
Zhang BL; Liu J; Diao G; Chang J; Xue J; Huang Z; Zhao H; Yu L; Cai J
J Hepatocell Carcinoma; 2024; 11():489-508. PubMed ID: 38463544
[TBL] [Abstract][Full Text] [Related]
11. A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Pan YX; Chen JC; Fang AP; Wang XH; Chen JB; Wang JC; He W; Fu YZ; Xu L; Chen MS; Zhang YJ; Li QJ; Zhou ZG
Cancer Commun (Lond); 2019 Oct; 39(1):55. PubMed ID: 31601270
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma.
Lin K; Huang Q; Huo Y; Zeng J; Ding Z; Guo P; Chen Z; Zeng Y; Liu J
Cancer Manag Res; 2020; 12():7771-7781. PubMed ID: 32943923
[TBL] [Abstract][Full Text] [Related]
15. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
16. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
17. A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation.
Zhang W; Bi Y; Yang K; Xie Y; Li Z; Yu X; Zhang L; Jiang W
Front Oncol; 2023; 13():1178123. PubMed ID: 37152021
[TBL] [Abstract][Full Text] [Related]
18. A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma.
Li X; Bi X; Zhao J; Li Z; Zhou J; Huang Z; Zhang Y; Zhao H; Cai J
Transl Cancer Res; 2021 Apr; 10(4):1773-1786. PubMed ID: 35116501
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
Zang Y; Long P; Wang M; Huang S; Chen C
Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
[No Abstract] [Full Text] [Related]
20. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments.
Zhao LY; Yang DD; Ma XK; Liu MM; Wu DH; Zhang XP; Ruan DY; Lin JX; Wen JY; Chen J; Lin Q; Dong M; Qi JJ; Hu PS; Zeng ZL; Chen ZH; Wu XY
J Cancer; 2019; 10(10):2299-2311. PubMed ID: 31258733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
